These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9585393)

  • 21. Insulin therapy at onset of type 2 diabetes mellitus--a new concept.
    Sahay BK
    J Assoc Physicians India; 2011 Apr; 59 Suppl():13-5. PubMed ID: 21818993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes mellitus. Distinguishing between patients receiving insulin and those requiring insulin therapy.
    Mahler RJ
    West J Med; 1974 May; 120(5):358-62. PubMed ID: 4839480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin--not always a life sentence: withdrawal of insulin therapy in non-insulin dependent diabetes.
    Cohen M; Crosbie C; Cusworth L; Zimmet P
    Diabetes Res; 1984 May; 1(1):31-4. PubMed ID: 6397285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dietary therapy on pancreatic beta cell function in noninsulin-dependent diabetes mellitus.
    Juang JH; Wang PW; Huang MJ
    J Formos Med Assoc; 1990 Aug; 89(8):672-6. PubMed ID: 1981229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient type 2 diabetes mellitus in a raccoon (Procyon lotor).
    McCain S; Kirk C; Ramsay E
    J Zoo Wildl Med; 2008 Dec; 39(4):622-5. PubMed ID: 19110706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The course of asymptomatic diabetes under varying preventive therapy--concluding report of a 5-year prospective study].
    Panzram G; Adolph W
    Z Gesamte Inn Med; 1977 Oct; 32(19):475-8. PubMed ID: 595718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment.
    Rudenski AS; Hadden DR; Atkinson AB; Kennedy L; Matthews DR; Merrett JD; Pockaj B; Turner RC
    Diabet Med; 1988 Jan; 5(1):36-41. PubMed ID: 2964326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose tolerance in patients with oral symptoms.
    Chinn H; Brody H; Silverman S; DiRaimondo V
    J Oral Ther Pharmacol; 1966 Jan; 2(4):261-9. PubMed ID: 5902252
    [No Abstract]   [Full Text] [Related]  

  • 29. Antipsychotic drugs may worsen metabolic control in type 2 diabetes mellitus.
    Spoelstra JA; Stolk RP; Cohen D; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    J Clin Psychiatry; 2004 May; 65(5):674-8. PubMed ID: 15163254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Greater use of insulin by southern European compared with Anglo-Celt patients with type 2 diabetes: the Fremantle Diabetes Study.
    Clifford RM; Davis WA; Cull CA; Bruce DG; Batty KT; Davis TM
    Eur J Endocrinol; 2004 Nov; 151(5):579-86. PubMed ID: 15538936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duration of residual B-cell function in maturity-onset diabetes.
    Cignarelli M; Cospite MR; Stefanelli G; Guastamacchia E; Nardelli G; Giorgino R
    Acta Diabetol Lat; 1984; 21(2):161-6. PubMed ID: 6382892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deteriorating beta-cell function in type 2 diabetes: a long-term model.
    Bagust A; Beale S
    QJM; 2003 Apr; 96(4):281-8. PubMed ID: 12651972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Predictors of Progressive Beta-Cell Failure in Type 2 Diabetes.
    Irace C; Tripolino C; Carallo C; Scavelli FB; Valle ED; Cortese C; Gnasso A
    J Investig Med; 2015 Aug; 63(6):802-5. PubMed ID: 26057560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Putting insulin resistance into context by dietary reversal of type 2 diabetes.
    Taylor R
    J R Coll Physicians Edinb; 2017 Jun; 47(2):168-171. PubMed ID: 28675193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of the individual initial vegetative condition for the testing of drugs on the healthy person and for the effect of drugs on patients].
    Fahrner HA
    Hippokrates; 1967 Jul; 38(14):549-59. PubMed ID: 4872495
    [No Abstract]   [Full Text] [Related]  

  • 36. Predicting future treatment of diabetes mellitus from characteristics available at presentation.
    MacIver DH; McNally PG; Shaw DE; Hearnshaw JR
    Diabet Med; 1988 Nov; 5(8):766-70. PubMed ID: 2975569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):837-53. PubMed ID: 9742976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary Fibre for the Prevention of Post-Pancreatitis Diabetes Mellitus: A Review of the Literature and Future Research Directions.
    Li X; Petrov MS
    Nutrients; 2024 Feb; 16(3):. PubMed ID: 38337719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 2 diabetes progression in an adult Ugandan population with new-onset diabetes: an observational prospective study.
    Kibirige D; Sekitoleko I; Lumu W; Nyirenda MJ
    BMC Prim Care; 2023 Oct; 24(1):214. PubMed ID: 37858088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety evaluation of human umbilical cord-mesenchymal stem cells in type 2 diabetes mellitus treatment: A phase 2 clinical trial.
    Lian XF; Lu DH; Liu HL; Liu YJ; Yang Y; Lin Y; Xie F; Huang CH; Wu HM; Long AM; Hui CJ; Shi Y; Chen Y; Gao YF; Zhang F
    World J Clin Cases; 2023 Jul; 11(21):5083-5096. PubMed ID: 37583846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.